EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Penumbra's enterprise value is $7,906 Mil.
Penumbra's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $1,059 Mil. Therefore, Penumbra's EV-to-Revenue for today is 7.47.
The historical rank and industry rank for Penumbra's EV-to-Revenue or its related term are showing as below:
PEN'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.31 Med: 10.67 Max: 19.1
Current: 7.47
During the past 12 years, the highest EV-to-Revenue of Penumbra was 19.10. The lowest was 1.31. And the median was 10.67.
PEN's EV-to-Revenue is ranked worse than 77.18% of 824
companies
in the Medical Devices & Instruments industry
Industry Median: 3.05
vs PEN: 7.47
As of today (2024-04-24), Penumbra's stock price is $206.15.
Penumbra's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $27.00. Therefore, Penumbra's PS Ratio for today is 7.64.
Penumbra EV-to-Revenue Historical Data
The historical data trend for Penumbra's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Penumbra's EV-to-Revenue
For the Medical Devices subindustry, Penumbra's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Penumbra's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Penumbra's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Penumbra's EV-to-Revenue falls into.
Penumbra's current Enterprise Value is $7,906 Mil.
Penumbra's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,059 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Penumbra's share price for today is $206.15.
Penumbra's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $27.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Penumbra EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Penumbra's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PEN has been successfully added to your 